Friday, August 25, 2023 6:05:10 PM
Highlighted proposed terms for the 60% acquisition are that two payments totaling $40 million will be made. The initial payment, amounting to up to $20 million can be made, at the election of the Tekmovil shareholders either in cash or through TPT Global Tech Series E Preferred Shares, but no less than $10 million in cash paid by October 31, 2023, unless extended by Tekmovil shareholders, is required to close. Any balance on the first payment may be in the form of a promissory note to be settled on or before March 31, 2024, using the proceeds generated from TPT's proposed public offering. The second payment of $20 million, at the election of the Tekmovil shareholders, can be made either in cash or through TPT Global Tech Series E Preferred Shares. The finalization of these payments is proposed to occur by March 31, 2024, unless extended by Tekmovil shareholders. It is also proposed that up to $80 million of additional funds raised through TPT's public offering will be used to assist in the restructuring of senior debt of Tekmovil through intercompany loans. The proposed intercompany loans will include a 5-year term, with provisions for accelerated repayment to TPT."
Recent TPTW News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 10:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 07:47:35 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/13/2024 06:17:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:00:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 09:52:34 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 06:06:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:06:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/27/2023 08:11:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 05:43:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 01:31:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 08:21:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 07:44:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 05:49:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 07:18:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/05/2023 09:02:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 06/29/2023 04:15:04 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM